Endpoint definition
↥| Name | ALCO_PRESCRIPTION |
|---|---|
| Long name | Use of disulfiram, acamprosate or naltrexone |
| Medicine purchases: ATC codes | N07BB01|N07BB03|N07BB04 |
| Level in the ICD-hierarchy | 2 |
| First defined in version | DF2 |
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1588 | 521 | 1067 |
| Unadjusted prevalence (%) | 0.73 | 0.42 | 1.13 |
| Mean age at first event (years) | 42.03 | 41.10 | 42.49 |
| Case fatality at 5-years (%) | 0.57 | 0.38 | 0.66 |
Longitudinal metrics
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 2.0 | 2.0 | 2.0 |
| Recurrence at 6 months (%) | 33.86 | 34.12 | 33.73 |
Survival analyses between endpoints
↥Plot
before Use of disulfiram, acamprosate or naltrexone
after Use of disulfiram, acamprosate or naltrexone
Loading survival analyses plot…
Table
Loading survival analyses table…